nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—hindbrain—epilepsy syndrome	0.0284	0.123	CbGeAlD
Masoprocol—IGF1R—brainstem—epilepsy syndrome	0.0163	0.0703	CbGeAlD
Masoprocol—IGF1R—forebrain—epilepsy syndrome	0.0157	0.0678	CbGeAlD
Masoprocol—IGF1R—telencephalon—epilepsy syndrome	0.0144	0.0624	CbGeAlD
Masoprocol—CYP2J2—forebrain—epilepsy syndrome	0.0106	0.046	CbGeAlD
Masoprocol—CYP2J2—telencephalon—epilepsy syndrome	0.00979	0.0423	CbGeAlD
Masoprocol—IGF1R—head—epilepsy syndrome	0.00899	0.0388	CbGeAlD
Masoprocol—IGF1R—nervous system—epilepsy syndrome	0.00852	0.0368	CbGeAlD
Masoprocol—IGF1R—central nervous system—epilepsy syndrome	0.0082	0.0355	CbGeAlD
Masoprocol—IGF1R—cerebellum—epilepsy syndrome	0.00802	0.0347	CbGeAlD
Masoprocol—LTB4R—brain—epilepsy syndrome	0.00789	0.0341	CbGeAlD
Masoprocol—CYP2J2—medulla oblongata—epilepsy syndrome	0.00769	0.0332	CbGeAlD
Masoprocol—CYP2J2—midbrain—epilepsy syndrome	0.00703	0.0304	CbGeAlD
Masoprocol—CYP2J2—spinal cord—epilepsy syndrome	0.00686	0.0296	CbGeAlD
Masoprocol—IGF1R—brain—epilepsy syndrome	0.00651	0.0281	CbGeAlD
Masoprocol—CYP2J2—head—epilepsy syndrome	0.00609	0.0263	CbGeAlD
Masoprocol—CYP19A1—forebrain—epilepsy syndrome	0.0058	0.025	CbGeAlD
Masoprocol—CYP2J2—nervous system—epilepsy syndrome	0.00578	0.025	CbGeAlD
Masoprocol—CYP2J2—central nervous system—epilepsy syndrome	0.00556	0.024	CbGeAlD
Masoprocol—CYP2J2—cerebellum—epilepsy syndrome	0.00544	0.0235	CbGeAlD
Masoprocol—ALOX5—head—epilepsy syndrome	0.0048	0.0207	CbGeAlD
Masoprocol—ALOX5—nervous system—epilepsy syndrome	0.00455	0.0197	CbGeAlD
Masoprocol—CYP2J2—brain—epilepsy syndrome	0.00442	0.0191	CbGeAlD
Masoprocol—ALOX5—central nervous system—epilepsy syndrome	0.00438	0.0189	CbGeAlD
Masoprocol—ALOX5—cerebellum—epilepsy syndrome	0.00428	0.0185	CbGeAlD
Masoprocol—ALOX5—brain—epilepsy syndrome	0.00348	0.015	CbGeAlD
Masoprocol—CYP19A1—head—epilepsy syndrome	0.00332	0.0143	CbGeAlD
Masoprocol—CYP19A1—nervous system—epilepsy syndrome	0.00315	0.0136	CbGeAlD
Masoprocol—CYP19A1—central nervous system—epilepsy syndrome	0.00303	0.0131	CbGeAlD
Masoprocol—CYP19A1—brain—epilepsy syndrome	0.0024	0.0104	CbGeAlD
Masoprocol—Dopamine—HTR7—epilepsy syndrome	0.00149	0.31	CrCbGaD
Masoprocol—Dopamine—SLC6A4—epilepsy syndrome	0.000977	0.203	CrCbGaD
Masoprocol—Dopamine—CYP2C19—epilepsy syndrome	0.000926	0.192	CrCbGaD
Masoprocol—L-DOPA—CYP2D6—epilepsy syndrome	0.000739	0.153	CrCbGaD
Masoprocol—Dopamine—CYP2D6—epilepsy syndrome	0.000687	0.142	CrCbGaD
Masoprocol—IGF1R—Signaling Pathways—CHRM2—epilepsy syndrome	0.000236	0.000309	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000236	0.000309	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000236	0.000309	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NPY—epilepsy syndrome	0.000234	0.000307	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000234	0.000307	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000234	0.000306	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GABBR1—epilepsy syndrome	0.000229	0.0003	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AGT—epilepsy syndrome	0.000228	0.000299	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—AKT1—epilepsy syndrome	0.000227	0.000297	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CRH—epilepsy syndrome	0.000226	0.000296	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HSPB1—epilepsy syndrome	0.000226	0.000296	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL3—epilepsy syndrome	0.000226	0.000296	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL2—epilepsy syndrome	0.000226	0.000296	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—OXT—epilepsy syndrome	0.000226	0.000296	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.000224	0.000293	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TXNRD1—epilepsy syndrome	0.000223	0.000293	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCR5—epilepsy syndrome	0.000223	0.000292	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	0.000223	0.000291	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PNPO—epilepsy syndrome	0.000223	0.000291	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	0.000223	0.000291	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GAMT—epilepsy syndrome	0.000223	0.000291	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CHRM3—epilepsy syndrome	0.00022	0.000288	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—KCNJ11—epilepsy syndrome	0.00022	0.000288	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRH3—epilepsy syndrome	0.00022	0.000288	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000218	0.000286	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AQP1—epilepsy syndrome	0.000217	0.000284	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—OPRM1—epilepsy syndrome	0.000216	0.000283	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000211	0.000276	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TSC1—epilepsy syndrome	0.00021	0.000275	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTK2B—epilepsy syndrome	0.00021	0.000275	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000208	0.000273	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AGT—epilepsy syndrome	0.000207	0.000271	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—QDPR—epilepsy syndrome	0.000207	0.000271	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA4—epilepsy syndrome	0.000207	0.000271	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	0.000206	0.00027	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000205	0.000268	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NTRK2—epilepsy syndrome	0.000204	0.000268	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SST—epilepsy syndrome	0.000204	0.000268	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR3—epilepsy syndrome	0.000204	0.000268	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR2—epilepsy syndrome	0.000204	0.000268	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DUSP6—epilepsy syndrome	0.000203	0.000265	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000201	0.000263	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRA2A—epilepsy syndrome	0.0002	0.000262	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NPY—epilepsy syndrome	0.000199	0.000261	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000199	0.000261	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PLAT—epilepsy syndrome	0.000199	0.000261	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CHRM3—epilepsy syndrome	0.000196	0.000257	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—KCNJ11—epilepsy syndrome	0.000196	0.000257	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—COX3—epilepsy syndrome	0.000195	0.000255	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CRH—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—OXT—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL12—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL3—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL2—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HSPB1—epilepsy syndrome	0.000192	0.000252	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—POMC—epilepsy syndrome	0.000192	0.000251	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000191	0.000251	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000191	0.000249	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JUNB—epilepsy syndrome	0.000189	0.000247	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CNR1—epilepsy syndrome	0.000189	0.000247	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PLCB1—epilepsy syndrome	0.000188	0.000246	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	0.000184	0.000242	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	0.000184	0.000242	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	0.000184	0.000242	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	0.000184	0.000242	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PFKL—epilepsy syndrome	0.000184	0.000242	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	0.000184	0.000241	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HTR7—epilepsy syndrome	0.000184	0.000241	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000183	0.000239	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.00018	0.000236	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCG2—epilepsy syndrome	0.000179	0.000235	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.000179	0.000235	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000179	0.000234	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTK2B—epilepsy syndrome	0.000179	0.000234	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HBEGF—epilepsy syndrome	0.000179	0.000234	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TSC1—epilepsy syndrome	0.000179	0.000234	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT3—epilepsy syndrome	0.000175	0.00023	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2C19—epilepsy syndrome	0.000175	0.000229	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—POMC—epilepsy syndrome	0.000174	0.000228	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SST—epilepsy syndrome	0.000174	0.000228	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NTRK2—epilepsy syndrome	0.000174	0.000228	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR2—epilepsy syndrome	0.000174	0.000228	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP11A1—epilepsy syndrome	0.000174	0.000228	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000173	0.000226	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DUSP6—epilepsy syndrome	0.000172	0.000226	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADAM10—epilepsy syndrome	0.000171	0.000224	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL2—epilepsy syndrome	0.000171	0.000223	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRA2A—epilepsy syndrome	0.00017	0.000223	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.00017	0.000222	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLAT—epilepsy syndrome	0.000169	0.000222	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—UPB1—epilepsy syndrome	0.000169	0.000221	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NEU1—epilepsy syndrome	0.000169	0.000221	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ATIC—epilepsy syndrome	0.000169	0.000221	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.000165	0.000216	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL12—epilepsy syndrome	0.000163	0.000214	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000163	0.000214	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	0.000162	0.000213	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—S100B—epilepsy syndrome	0.000162	0.000212	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JUNB—epilepsy syndrome	0.00016	0.00021	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CNR1—epilepsy syndrome	0.00016	0.00021	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SOCS3—epilepsy syndrome	0.00016	0.00021	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDC42—epilepsy syndrome	0.00016	0.00021	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCG2—epilepsy syndrome	0.00016	0.000209	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLCB1—epilepsy syndrome	0.00016	0.000209	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000157	0.000206	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GBE1—epilepsy syndrome	0.000157	0.000205	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2D6—epilepsy syndrome	0.000157	0.000205	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	0.000157	0.000205	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR7—epilepsy syndrome	0.000157	0.000205	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2C19—epilepsy syndrome	0.000156	0.000204	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AVP—epilepsy syndrome	0.000155	0.000203	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP11A1—epilepsy syndrome	0.000155	0.000203	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000154	0.000201	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000153	0.000201	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HBEGF—epilepsy syndrome	0.000152	0.000199	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADRA2A—epilepsy syndrome	0.000149	0.000196	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT3—epilepsy syndrome	0.000149	0.000195	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—BCHE—epilepsy syndrome	0.000149	0.000195	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	0.000147	0.000193	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HES1—epilepsy syndrome	0.000147	0.000192	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADAM10—epilepsy syndrome	0.000146	0.000191	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.000144	0.000188	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	0.000143	0.000188	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FYN—epilepsy syndrome	0.000142	0.000187	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—H2AFX—epilepsy syndrome	0.000142	0.000186	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC2A1—epilepsy syndrome	0.000142	0.000186	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MEF2C—epilepsy syndrome	0.000142	0.000186	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PLCB1—epilepsy syndrome	0.00014	0.000184	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.00014	0.000184	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2D6—epilepsy syndrome	0.00014	0.000183	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TH—epilepsy syndrome	0.00014	0.000183	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NT5E—epilepsy syndrome	0.00014	0.000183	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALAD—epilepsy syndrome	0.00014	0.000183	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—S100B—epilepsy syndrome	0.000138	0.00018	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000138	0.00018	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000137	0.000179	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SOCS3—epilepsy syndrome	0.000136	0.000179	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDC42—epilepsy syndrome	0.000136	0.000178	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NGF—epilepsy syndrome	0.000135	0.000177	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	0.000133	0.000175	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	0.000133	0.000175	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADRA2A—epilepsy syndrome	0.000133	0.000174	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—BCHE—epilepsy syndrome	0.000133	0.000174	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AVP—epilepsy syndrome	0.000132	0.000172	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR5—epilepsy syndrome	0.000132	0.000172	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	0.000131	0.000171	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HTR2A—epilepsy syndrome	0.000129	0.000169	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADSL—epilepsy syndrome	0.000128	0.000167	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC2A1—epilepsy syndrome	0.000126	0.000166	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GLUL—epilepsy syndrome	0.000125	0.000164	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PLCB1—epilepsy syndrome	0.000125	0.000164	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TH—epilepsy syndrome	0.000125	0.000163	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HES1—epilepsy syndrome	0.000125	0.000163	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	0.000123	0.000161	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000123	0.000161	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TSC2—epilepsy syndrome	0.000122	0.00016	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AGT—epilepsy syndrome	0.000122	0.00016	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FYN—epilepsy syndrome	0.000121	0.000159	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—H2AFX—epilepsy syndrome	0.000121	0.000158	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MEF2C—epilepsy syndrome	0.00012	0.000158	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOE—epilepsy syndrome	0.00012	0.000157	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KDR—epilepsy syndrome	0.000117	0.000154	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMOX1—epilepsy syndrome	0.000117	0.000153	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000116	0.000152	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NGF—epilepsy syndrome	0.000115	0.000151	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	0.000115	0.000151	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAT—epilepsy syndrome	0.000115	0.000151	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PRKCB—epilepsy syndrome	0.000113	0.000148	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6ST—epilepsy syndrome	0.000113	0.000147	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR5—epilepsy syndrome	0.000112	0.000147	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCB1—epilepsy syndrome	0.000112	0.000147	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AQP1—epilepsy syndrome	0.000112	0.000146	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR2A—epilepsy syndrome	0.00011	0.000144	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000107	0.000141	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TSC2—epilepsy syndrome	0.000104	0.000136	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—epilepsy syndrome	0.000104	0.000136	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AGT—epilepsy syndrome	0.000104	0.000136	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMOX1—epilepsy syndrome	0.000104	0.000136	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—POMC—epilepsy syndrome	0.000103	0.000135	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAT—epilepsy syndrome	0.000103	0.000134	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOE—epilepsy syndrome	0.000102	0.000133	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	0.000101	0.000132	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	0.000101	0.000132	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL2—epilepsy syndrome	0.000101	0.000132	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KDR—epilepsy syndrome	9.98e-05	0.000131	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCB1—epilepsy syndrome	9.98e-05	0.000131	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PRKCB—epilepsy syndrome	9.61e-05	0.000126	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6ST—epilepsy syndrome	9.57e-05	0.000125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.41e-05	0.000123	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—epilepsy syndrome	9.28e-05	0.000122	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.22e-05	0.000121	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	9.18e-05	0.00012	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AGT—epilepsy syndrome	9.13e-05	0.00012	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGF2—epilepsy syndrome	9.1e-05	0.000119	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOE—epilepsy syndrome	8.95e-05	0.000117	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—POMC—epilepsy syndrome	8.75e-05	0.000115	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL2—epilepsy syndrome	8.57e-05	0.000112	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RELA—epilepsy syndrome	8.45e-05	0.000111	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MTOR—epilepsy syndrome	8.29e-05	0.000109	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	8.24e-05	0.000108	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AGT—epilepsy syndrome	8.14e-05	0.000107	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	8.03e-05	0.000105	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	7.98e-05	0.000104	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOE—epilepsy syndrome	7.97e-05	0.000104	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.92e-05	0.000104	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGF2—epilepsy syndrome	7.74e-05	0.000101	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—epilepsy syndrome	7.69e-05	0.000101	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—POMC—epilepsy syndrome	7.68e-05	0.000101	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—epilepsy syndrome	7.62e-05	9.98e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JUN—epilepsy syndrome	7.4e-05	9.69e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.22e-05	9.46e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—epilepsy syndrome	7.2e-05	9.43e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	7.2e-05	9.43e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RELA—epilepsy syndrome	7.19e-05	9.41e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MTOR—epilepsy syndrome	7.05e-05	9.23e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALB—epilepsy syndrome	7.01e-05	9.17e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—epilepsy syndrome	6.99e-05	9.15e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	6.86e-05	8.98e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—POMC—epilepsy syndrome	6.85e-05	8.97e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BCHE—epilepsy syndrome	6.83e-05	8.94e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SRC—epilepsy syndrome	6.64e-05	8.7e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	6.51e-05	8.53e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—epilepsy syndrome	6.48e-05	8.49e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—epilepsy syndrome	6.47e-05	8.47e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	6.44e-05	8.43e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TH—epilepsy syndrome	6.42e-05	8.4e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.32e-05	8.27e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JUN—epilepsy syndrome	6.3e-05	8.24e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALB—epilepsy syndrome	6.24e-05	8.18e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—epilepsy syndrome	6.13e-05	8.03e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—epilepsy syndrome	6.13e-05	8.02e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SRC—epilepsy syndrome	5.65e-05	7.39e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—epilepsy syndrome	5.5e-05	7.2e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—epilepsy syndrome	5.46e-05	7.15e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	5.36e-05	7.01e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAT—epilepsy syndrome	5.29e-05	6.92e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	5.14e-05	6.73e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—epilepsy syndrome	4.78e-05	6.26e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AGT—epilepsy syndrome	4.19e-05	5.49e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—epilepsy syndrome	4.13e-05	5.4e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOE—epilepsy syndrome	4.11e-05	5.38e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—POMC—epilepsy syndrome	3.53e-05	4.62e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—epilepsy syndrome	3.51e-05	4.59e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALB—epilepsy syndrome	3.22e-05	4.21e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—epilepsy syndrome	3.08e-05	4.03e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	2.81e-05	3.68e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—epilepsy syndrome	2.75e-05	3.59e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—epilepsy syndrome	1.41e-05	1.85e-05	CbGpPWpGaD
